IntelliCell BioSciences Files Pre-IND With FDA for Osteoarthritis Lead by Dr. James Andrews

Marketwired (Fri, Aug 1, 2014)

Sports Illustrated References IntelliCell BioSciences Technology for Athletes

Marketwired (Thurs, July 31, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements

EDGAR Online Financials (Tues, July 15, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events

EDGAR Online Financials (Wed, June 25, 2014)

INTELLICELL BIOSCIENCES, INC. Financials

EDGAR Online Financials (Wed, June 25, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online Financials (Wed, June 18, 2014)

INTELLICELL BIOSCIENCES, INC. Financials

EDGAR Online Financials (Tues, May 20, 2014)

IntelliCell BioSciences announces That Merril Hoge has joined Its Board of Advisors

PR Newswire (Tues, May 13, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K, Annual Report

EDGAR Online (Mon, May 12, 2014)

IntelliCell BioSciences Announces Positive Final Ruling Against Ironridge Global IV, LTD., and TCA Global Credit Master Fund, LP

PR Newswire (Wed, May 7, 2014)

IntelliCell BioSciences' Stromal Vascular Cell Technology Used For Restorative Cardiac Function With Dr. Zain Khalpey IND

PR Newswire (Tues, April 29, 2014)

inVentiv Health Clinical Engaged by IntelliCell Biosciences, a Regenerative Medicine Company, as Clinical Research Organization for Osteoarthritis

PR Newswire (Tues, April 15, 2014)

IntelliCell BioSciences Has Engaged inVentiv Clinical as CRO for Osteoarthritis IND Lead by Dr. James Andrews

Marketwired (Mon, April 14, 2014)

IntelliCell BioSciences Has Received Its Hong Kong Patent Application Notice for ULTRASONIC CAVITATION

Marketwired (Wed, April 2, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an

EDGAR Online (Fri, Mar 28, 2014)

IntelliCell BioSciences Announces That Dr. Steven Victor Was Thanked for His Work in Brain Trauma Research for Veterans

Marketwired (Thurs, Mar 27, 2014)

IntelliCell BioSciences Announces That It Will Develop Investigational Clinical Protocol Studies for the Treatment of ALS With Dr. Manuel Trujillo

Marketwired (Mon, Mar 24, 2014)

IntelliCell Biosciences Announces That It Is Collaborating With the Global Alliance for Innovation in Neuroscience, Inc. (GAIN) for Autism, Dementia and Brain Trauma

Marketwired (Wed, Mar 19, 2014)

IntelliCell BioSciences Announces It Will File an IND for Osteoarthritis of the Knee in Conjunction With the Andrews's Research and Educational Foundation

Marketwired (Mon, Mar 17, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an

EDGAR Online (Wed, Mar 12, 2014)

IntelliCell BioSciences Joins Forces With Dr. James Andrews's Research and Educational Foundation

Marketwired (Wed, Mar 12, 2014)

IntelliCell BioSciences Raises Capital for Strategic Growth

Marketwired (Wed, Mar 12, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi

EDGAR Online (Mon, Mar 10, 2014)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits

EDGAR Online (Fri, Jan 31, 2014)

IntelliCell BioSciences Announces Favorable Ruling Against Ironridge Global IV, LTD., and TCA Global Credit Masterfund, LP

Marketwired (Wed, Jan 29, 2014)

IntelliCell Provides Shareholder Update

Marketwired (Tues, Dec 10, 2013)

IntelliCell Biosciences' Cellular Therapy Treatment Yields Positive Results in Multiple Sclerosis Patients

Marketwired (Tue, Nov 12, 2013)

UPDATE: IntelliCell BioSciences Appoints Mr. Michael Hershman as Chairman of the Board of Directors

Marketwired (Thu, Oct 31, 2013)

IntelliCell BioSciences Appoints Mr. Michael Herschman as Chairman of the Board of Directors

Marketwired (Wed, Oct 30, 2013)

IntelliCell BioSciences Receives Notice of Its Thailand Patent Application for Its Stem Cell Extraction Technology

Marketwired (Tue, Oct 22, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q/A, Quarterly Report

EDGAR Online (Fri, Oct 18, 2013)

IntelliCell Biosciences Announces the Addition of Mr. Sam Khashman to Board of Directors

Marketwired (Fri, Oct 18, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Wed, Oct 16, 2013)

IntelliCell Biosciences Engages MD Global Partners, LLC as Advisor to the Company

Marketwired (Thu, Oct 10, 2013)

IntelliCell Biosciences Stem Cells Used to Successfully Treat Bell's Palsy and Type I Diabetes Patient

Marketwired (Wed, Oct 9), 2013

IntelliCell Biosciences Becomes Fully Reporting

Marketwired (Mon, Oct 7, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online (Thu, Oct 3, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online (Tue, Oct 1, 2013)

IntelliCell Biosciences Announces it Has Received Notification That International Patents for Canada, Europe and Korea Are Filed and Pending Approvals

Accesswire (Thu, Sep 19, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Wed, Sep 18, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K, Annual Report

EDGAR Online (Mon, Sep 16, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events

EDGAR Online (Tue, Aug 27, 2013)

IntelliCell Biosciences Announces it Has Received Notification That International Patents for Canada, Europe and Korea Are Filed and Pending Approvals

Accesswire (Thu, Sep 19, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Wed, Sep 18, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K, Annual Report

EDGAR Online (Mon, Sep 16, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events

EDGAR Online (Tue, Aug 27, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events

EDGAR Online (Tue, Aug 13, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events

EDGAR Online (Mon, Aug 12, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Fri, Aug 9, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Ob

EDGAR Online (Mon, Aug 5, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Wed, Jul 31, 2013)

IntelliCell BioSciences Discusses their Stem Cell Treatment Technology in Online Interview

Accesswire (Fri, Jul 12, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Fri, Jul 12, 2013)

Maxim Group Issues Stem Cell Sector Report on IntelliCell BioSciences Based on Treatment Process

Accesswire (Mon, Jul 8, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Mon, Jul 8, 2013)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Wed, Jun 19, 2013)

IntelliCell BioSciences Announces That Dr Zain Khalpey Has Joined Its Advisory Board

ACCESSWIRE (Jun 17, 2013)

IntelliCell BioSciences Announces That Its Cellular Tissue Laboratory was inspected by FDA

PR Newswire (Jun 14, 2013)

IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology

PR Newswire (Jun 13, 2013)

IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"

PR Newswire (Jan 22, 2013)

IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology

PR Newswire (Dec 10, 2012)

IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey

PR Newswire (Nov 28, 2012)

IntelliCell BioSciences Issues Corrected Listing For Human Cells, Tissues, and Cellular Based Products

PR Newswire (Thu, Nov 15, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Prin

PR Newswire (Thu, Nov 8, 2012)

IntelliCell BioSciences Announces FDA Listing For Human Cells, Tissues, and Cellular Based Products

PR Newswire (Thu, Nov 8, 2012)

IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors

PR Newswire (Mon, Oct 29, 2012)

IntelliCell BioSciences Announces the Manufacture of Stromal Vascular Fraction Cells from Non-Living Donated Adipose Tissue

PR Newswire (Tues, Oct 9, 2012)

IntelliCell Announces Research Tissue Bank License

PR Newswire (Thurs, Oct 4, 2012)

IntelliCell BioSciences Announces Clinical Study For Diabetic Critical Limb Ischemia

PR Newswire (Thurs, Sep 13, 2012)

INTELLICELL BIOSCIENCES, INC. Financials

EDGAR Online Financials (Sat, Aug 25, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online (Tue, Aug 21, 2012)

IntelliCell BioSciences, Inc. New Lab at 460 Park Avenue, New York, NY is cGTP Compliant

PR Newswire (Tue, July 24, 2012)

IntelliCell BioSciences Files Patent Application for a New Research Technique

PR Newswire (Mon, July 23, 2012)

IntelliCell Opens New Flagship Medical Facility

PR Newswire (Tue, June 4, 2012)

IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research

PR Newswire (Tue, May 22, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online (Mon, May 21, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

EDGAR Online (Fri, May 18, 2012)

IntelliCell BioSciences Announces Frederick Frank as Executive Advisor to Board of Directors

PR Newswire (Fri, May 10, 2012)

INTELLICELL BIOSCIENCES, INC. Financials

EDGAR Online Financials (Thu, April 26, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K/A, Annual Report

EDGAR Online (Mon, April 23, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an

EDGAR Online (Thu, April 19, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K, Annual Report

EDGAR Online (Wed, April 18, 2012)

IntelliCell BioSciences Expands Management Team

PR Newswire (Thu, April 12, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an

EDGAR Online (Wed, April 11, 2012)

IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand

PR Newswire (Tue, April 10, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits

EDGAR Online (Tue, Apr 3, 2012)

IntelliCell BioSciences, Inc. to Address FDA Warning Letter

PR Newswire (Wed, March 28, 2012)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits

EDGAR Online (Wed, March 14, 2012)

IntelliCell Presents at Roth Conference March 14th

Business Wire (Tue, March 13)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

EDGAR Online (Thu, Feb 23)

IntelliCell BioScience Inc. Procedure Enables Norwegian Star Basketball Player to Fully Recover from Patella Tendinitis to Play for Manhattan College

Business Wire (Tue, Feb 21)

IntelliCell Demonstrates at the American Sports Medicine Institute Held in Conjunction with and at the Andrews Sports Medicine & Orthopedic Center in Birmingham, AL

Business Wire (Tue, Feb 7)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Sta

EDGAR Online (Fri, Feb 3)

IntelliCell Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells

Business Wire (Thu, Jan 26)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers

EDGAR Online - Wednesday, Jan 25, 2012 (2:42PM EST)

IntelliCell BioSciences Announces the Licensing of its Proprietary Patent, Pending Stomal Vascular Manufacturing Technology to IntelliCell BioSciences of Canada

Business Wire - Wednesday, Jan 11, 2012 (9:04AM EST)

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits

EDGAR Online - Tuesday, Jan 10, 2012

Intellicell Biosciences announces the licensing of its proprietary patent, pending stromal vascular fraction manufacturing technology

Business Wire - Tuesday, Jan 10, 2012

CORRECTING and REPLACING IntelliCell Biosciences Inc. Announces the Addition of World Renowned Orthopedic Surgeons and Sports Medicine Doctors to Medical Advisory Board

Business Wire - Monday, Jan 9, 2012 (2:42PM EST)

IntelliCell Biosciences Presents at BioTech Showcase Conference January 9, 2012

NEW YORK, NY--(Business Wire)--(January 5, 2012) - IntelliCell Biosciences, Inc. (OTCQB: SVFC.PK - News) (PINKSHEETS: SVFC.PK - News); ("IntelliCell") or the ("Company"), Dr. Steven Victor, Chairman of IntelliCell Biosciences will be presenting at the BioTech Showcase Conference on January 9, 2012 at 11:30 a.m. (PT). Parc 55 Wyndham San Francisco - Union 55 Cyril Magnin Street San Francisco, CA 94102 Admission Room #2.
Thu, Jan 5, 2012 1:58 PM


INTELLICELL BIOSCIENCES, INC. Financials

EDGAR Online Financials - Thursday, Dec 22, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi

EDGAR Online - Wednesday, Dec 21, 2011

IntelliCell BioSciences Inc. Announces James R. Andrews, M.D. Has Joined Its Medical Advisory Board

Business Wire - Wednesday, Dec 21, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online - Monday, Dec 19, 2011

IntelliCell BioSciences, Inc Announces Powerful Collaboration with Numoda Corporation

Business Wire - Tuesday, Dec 13, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi

EDGAR Online - Wednesday, Dec 7, 2011

Other Stem Cell Players Ready To Fill Void Left By Geron

Seeking Alpha - Wednesday, Nov 16, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Unregistered Sale of Equity Securities, Amendments to Articles of

EDGAR Online - Monday, Oct 31, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Amendments to Articles of

IEDGAR Online - Thursday, Oct 27, 2011

IntelliCell BioSciences Announces Study Published in The Journal of Implant & Advanced Clinical Dentistry

Marketwire - Wednesday, Oct 20, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi

EDGAR Online - Monday, Oct 19, 2011

IntelliCell BioSciences, Inc. Appoints Jack Schneider to Its Board of Advisors

Marketwire - Monday, Oct 19, 2011

IntelliCell BioSciences Out to Shake Up Regenerative Medicine With Disruptive Technology and Game Plan

Marketwire - Wednesday, Sep 28, 2011

IntelliCell BioSciences, Inc. Announces It Has Signed an Exclusive Supply and Sale Agreement With Millipore Corporation

Marketwire - Monday, Sep 26, 2011

IntelliCell BioSciences, Inc. Announces It Will Present at the Rodman & Renshaw Annual Global Investment Summit in New York

Marketwire - Monday, Sep 12, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an

EDGAR Online - Friday, Sep 2, 2011

IntelliCell BioSciences, Inc. Announces It Has Signed a Licensing Agreement With The PAWS Pet Company, Inc.

Marketwire - Tuesday, Aug 30, 2011

The PAWS Pet Company and IntelliCell BioSciences to Bring Regenerative Cell Therapy to Animals

Marketwire - Tuesday, Aug 30, 2011

Human Body's Fat Seen As best Source of Stem Cells For Regenerative Therapies

Forbes - Sunday, Aug 28, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report

EDGAR Online - Monday, Aug 22, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statemen

EDGAR Online - Thursday, Aug 18, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements

EDGAR Online - Tuesday, Aug 16, 2011

INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi

EDGAR Online - Thursday, Aug 11, 2011

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Baton Rouge

Marketwire - Thursday, Aug 4, 2011

IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Orlando

NEW YORK, NY--(Aug 3, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult ...
8/3/2011 11:11:05 AM


IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Houston

NEW YORK, NY--(Aug 1, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult ...
8/1/2011 11:45:36 AM


IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Denver

NEW YORK, NY--(July 28, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult...
7/28/2011 11:54:56 AM


IntelliCell BioSciences' Stem Cell Technology Validated by Merck Subsidiary

NEW YORK, NY--(Jul 14, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult ...
7/14/2011 7:00:00 AM


IntelliCell BioSciences, Inc. Announces Name Change From Media Exchange Group, Inc. and New Trading Symbol "SVFC"

NEW YORK, NY--(July 7, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) and formerly ( OTCQB : CWLC ) ( PINKSHEETS : CWLC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vasc...
7/7/2011 7:00:00 AM